Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 27.3B | 27.9B | 26.6B | 26.4B |
Cost of revenue | 14.0B | 14.1B | 13.1B | 12.6B |
Gross profit | 13.3B | 13.8B | 13.5B | 13.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.1B | 2.9B | 2.9B | 2.4B |
Other operating expenses | 3.6B | 3.5B | 3.3B | 3.1B |
Operating income | 4.1B | 4.9B | 4.8B | 5.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 120M | 130M | 110M | 170M |
Other income expense | — | — | — | — |
Pretax income | 4.4B | 5.2B | 5.5B | 6.1B |
Tax provision | 960M | 1.1B | 1.2B | 1.3B |
Net income | 3.5B | 4.1B | 4.3B | 4.7B |
Basic EPS | — | 3.1 | 3.3 | 3.6 |
Diluted EPS | — | 3.1 | 3.3 | 3.6 |
Basic average shares | — | 1.3B | 1.3B | 1.3B |
Diluted average shares | — | 1.3B | 1.3B | 1.3B |
EBITDA | 5.1B | 5.8B | 6.0B | 6.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -20M | -70M | -100M | -100M |
Preferred stock dividends | 0 | 0 | 0 | 0 |